Personalis Company Leadership
| PSNL Stock | USD 9.37 0.60 6.02% |
Personalis employs about 228 people. The company is managed by 15 executives with a total tenure of roughly 532 years, averaging almost 35.0 years of service per executive, having 15.2 employees per reported executive. Inspection of Personalis' management performance can provide insight into the company performance.
Personalis | Build AI portfolio with Personalis Stock |
Personalis Management Team Effectiveness
The company has return on total asset (ROA) of (0.2095) % which means that it has lost $0.2095 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.437) %, meaning that it created substantial loss on money invested by shareholders. Personalis' management efficiency ratios could be used to measure how well Personalis manages its routine affairs as well as how well it operates its assets and liabilities.Personalis owns a total of 88.8 Million outstanding shares. Over half of Personalis' outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Also note that almost eight hundred ninety-six thousand nine hundred twenty-four invesors are currently shorting Personalis expressing very little confidence in its future performance.
Some institutional investors establish a significant position in stocks such as Personalis in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Personalis, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Personalis Workforce Comparison
Personalis is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 11,312. Personalis holds roughly 228 in number of employees claiming about 2.02% of equities under Health Care industry.
The company has Profit Margin (PM) of (1.07) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.61) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.61. Personalis Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Personalis insiders, such as employees or executives, is commonly permitted as long as it does not rely on Personalis' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Personalis insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Myers Woodrow A Jr over six months ago Acquisition by Myers Woodrow A Jr of 50000 shares of Personalis at 4.95 subject to Rule 16b-3 | ||
Christopher Hall over six months ago Disposition of 20459 shares by Christopher Hall of Personalis at 0.93 subject to Rule 16b-3 | ||
Shoff Lonnie over six months ago Acquisition by Shoff Lonnie of 30940 shares of Personalis subject to Rule 16b-3 | ||
Chen Richard over six months ago Acquisition by Chen Richard of 250000 shares of Personalis at 3.63 subject to Rule 16b-3 | ||
Aaron Tachibana over a year ago Disposition of 6865 shares by Aaron Tachibana of Personalis at 3.82 subject to Rule 16b-3 | ||
Chen Richard over a year ago Disposition of 921 shares by Chen Richard of Personalis at 3.79 subject to Rule 16b-3 | ||
Christopher Hall over a year ago Disposition of 26443 shares by Christopher Hall of Personalis at 5.38 subject to Rule 16b-3 | ||
Shoff Lonnie over a year ago Acquisition by Shoff Lonnie of 40000 shares of Personalis at 2.07 subject to Rule 16b-3 |
Personalis Notable Stakeholders
A Personalis stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Personalis often face trade-offs trying to please all of them. Personalis' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Personalis' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Christopher Hall | CEO President | Profile | |
| Aaron Tachibana | CFO COO | Profile | |
| Ashish Kheterpal | Senior Officer | Profile | |
| Stephen JD | Senior Officer | Profile | |
| Christian Haudenschild | Senior Operations | Profile | |
| DPHIL FRCP | CoFounder Board | Profile | |
| Carol Tillis | VP Admin | Profile | |
| MS MD | Executive Officer | Profile | |
| MD MS | VP Officer | Profile | |
| John West | CEO, CoFounder | Profile | |
| Michael Fitzpatrick | Vice Sales | Profile | |
| Atul Butte | CoFounder Board | Profile | |
| Deepshikha Bhandari | Quality Regulatory | Profile | |
| Stephane Mouradian | Senior Development | Profile | |
| Michael Snyder | CoFounder Board | Profile |
About Personalis Management Performance
The success or failure of an entity such as Personalis often depends on how effective the management is. Personalis management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Personalis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Personalis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Personalis, Inc. operates as a cancer genomics company worldwide. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California. Personalis operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 325 people.
Personalis Workforce Analysis
Traditionally, organizations such as Personalis use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Personalis within its industry.Personalis Manpower Efficiency
Return on Personalis Manpower
| Revenue Per Employee | 371.1K | |
| Revenue Per Executive | 5.6M | |
| Net Loss Per Employee | 356.5K | |
| Net Loss Per Executive | 5.4M | |
| Working Capital Per Employee | 753.9K | |
| Working Capital Per Executive | 11.5M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Personalis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. For more information on how to buy Personalis Stock please use our How to buy in Personalis Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Personalis. Anticipated expansion of Personalis directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Personalis assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Personalis requires distinguishing between market price and book value, where the latter reflects Personalis's accounting equity. The concept of intrinsic value—what Personalis' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Personalis' price substantially above or below its fundamental value.
It's important to distinguish between Personalis' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Personalis should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Personalis' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.